Clearside Biomedical (CLSD)
(Real Time Quote from BATS)
$1.39 USD
+0.02 (1.46%)
Updated Apr 24, 2024 10:46 AM ET
1-Strong Buy of 5 1
F Value B Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.14 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | 20.00% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.56 |
Next Year | -0.51 |
EPS (TTM) | -0.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.98M | 0.98M | 3.86M | 14.72M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 2.39M | 2.40M | 9.61M | 16.14M |
Low Estimate | 0.20M | 0.20M | 0.60M | 13.29M |
Year ago Sales | 0.00M | 1.02M | 8.23M | 3.86M |
Year over Year Growth Est. | NA | -3.92% | -53.12% | 281.61% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.14 | -0.14 | -0.56 | -0.51 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | -0.15 | -0.14 | -0.56 | -0.44 |
High Estimate | -0.12 | -0.12 | -0.48 | -0.44 |
Low Estimate | -0.16 | -0.16 | -0.63 | -0.58 |
Year ago EPS | -0.15 | -0.15 | -0.53 | -0.56 |
Year over Year Growth Est. | 6.67% | 6.67% | -5.66% | 8.33% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.14 | -0.14 | -0.56 | -0.51 |
7 Days Ago | -0.14 | -0.14 | -0.56 | -0.51 |
30 Days Ago | -0.14 | -0.14 | -0.56 | -0.51 |
60 Days Ago | -0.16 | -0.16 | -0.59 | -0.63 |
90 Days Ago | -0.16 | -0.16 | -0.59 | -0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.14 | -0.14 | -0.56 | -0.51 |
Zacks Consensus Estimate | -0.14 | -0.14 | -0.56 | -0.51 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.15 | -0.15 | -0.15 | NA |
Estimate | -0.10 | -0.16 | -0.14 | -0.14 | NA |
Difference | 0.02 | 0.01 | -0.01 | -0.01 | 0.00 |
Surprise | 20.00% | 6.25% | -7.14% | -7.14% | 2.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more